31st Annual North American Cystic Fibrosis Conference

W29 - W29: NT: Toward the Goal of a One-Time Cure: Challenges & Opportunities

Nov 4, 2017 10:30am ‐ Nov 4, 2017 11:50am


Description

Gene therapy provides the opportunity to cure all those affected by cystic fibrosis (CF), but this approach has been met with several challenges preventing its clinical success. The goal of this workshop is to address the current barriers to effective treatment of CF using gene therapy and introduce methods to overcome them using state-of-the art genetic and cell-based therapeutic approaches for CF.

Learning Objectives:

  1. Describe therapeutic approaches with the potential to provide long-lasting benefit in the treatment of cystic fibrosis.
  2. Identify the challenges remaining in achieving an effective one-time CF therapy using genetic and cell-based approaches.
  3. Explain the latest advances in genetic and cell-based approaches in the treatment of CF.

Workshop Chair(s):

  • Eric Alton, M.A., M.D., FRCP, F.Med.Sci., Professor of Gene Therapy & Respiratory Medicine/Honorary Consultant Physician, National Heart & Lung Institute
  • Gregg Duncan, Ph.D., University of Maryland

Workshop Speaker(s):

You must be logged in and own this session in order to post comments.